title: What is new in systemic lupus erythematosus.
abstract: Systemic lupus erythematosus is a heterogeneous rheumatic systemic disease with extremely varied clinical manifestations and a diverse pathogenesis, as illustrated in this review on the most relevant new knowledge related to the disease. Topics such as anemia, pathogenesis, cardiovascular risk assessment, antiphospholipid syndrome, prediction of damage and recent advances in treatment, including tolerogenic and biological agents, are discussed. Relevant contributions regarding classical therapies such as corticosteroid and antimalarials and their optimal use, as well as the roll of vitamin D, are also referred.
authors.affiliation: Servicio de Reumatología, Hospital Doctor Negrín, Las Palmas de Gran Canaria, Las Palmas, España. Electronic address: iruafer@gobiernodecanarias.org.
authors.forename: Iñigo
authors.initials: I
authors.lastname: Rúa-Figueroa Fernández de Larrinoa
mesh_terms: D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000209:etiology; D001685:Biological Factors / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000209:etiology; D018450:Disease Progression; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy / Q000209:etiology / Q000276:immunology / Q000503:physiopathology; D012307:Risk Factors; D014807:Vitamin D / Q000627:therapeutic use; D014815:Vitamins / Q000627:therapeutic use
chemical_list: D000893:Anti-Inflammatory Agents; D001685:Biological Factors; D014815:Vitamins; D014807:Vitamin D
keywords: Lupus eritematoso sistémico; Systemic lupus erythematosus